Gender
Item
the participant must be female.
boolean
C0079399 (UMLS CUI [1])
Age
Item
the participant must be greater than or equal to 35 years of age.
boolean
C0001779 (UMLS CUI [1])
Able to speak English Language
Item
the participant must be english-speaking.
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
At risk Increased Breast Carcinoma
Item
the participant must have been identified as being at increased risk for breast cancer as determined by the doctor/healthcare professional (hcp) . (increased risk for breast cancer does not have to be based on a gail score.)
boolean
C1444641 (UMLS CUI [1,1])
C0205217 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Specific patient counseling session | Discussion | Risk Breast Carcinoma | SERMs Risk Reduction Breast Carcinoma
Item
during the participant's counseling session, breast cancer risk and the use of serms for breast cancer risk reduction must have been discussed, as reported by the doctor/hcp who conducted the session. note: this criterion does not apply to participants who are asked before the counseling session to participate in the video recording component of dmp-1 at the selected nsabp sites.
boolean
C0199393 (UMLS CUI [1])
C0557061 (UMLS CUI [2])
C0035647 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C0732611 (UMLS CUI [4,1])
C1137094 (UMLS CUI [4,2])
C0678222 (UMLS CUI [4,3])
Invasive carcinoma of breast Previous
Item
previous invasive breast cancer of any type.
boolean
C0853879 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
DCIS Previous
Item
previous history of ductal carcinoma in situ (dcis).
boolean
C0007124 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Lobular carcinoma in situ of breast Previous | Mastectomy | Therapeutic radiology procedure | Hormone Therapy
Item
previous history of lobular carcinoma in situ (lcis) if treated with mastectomy, radiation therapy, or endocrine therapy.
boolean
C0279563 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0024881 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0279025 (UMLS CUI [4])
Study Subject Participation Status | Cancer prevention | Intervention pharmacological | Prevention of osteoporosis
Item
participation in any other cancer prevention study involving pharmacologic intervention(s) or osteoporosis prevention study involving pharmacologic intervention(s).
boolean
C2348568 (UMLS CUI [1])
C0281206 (UMLS CUI [2])
C0184661 (UMLS CUI [3,1])
C0205464 (UMLS CUI [3,2])
C3650929 (UMLS CUI [4])
Tamoxifen | Raloxifene | Selective Estrogen Receptor Modulators
Item
any history of or current tamoxifen, raloxifene, or other serm therapy for any reason. (participants are eligible if serm use has been discussed prior to the counseling session as long as serms were never used.)
boolean
C0039286 (UMLS CUI [1])
C0244404 (UMLS CUI [2])
C0732611 (UMLS CUI [3])